This study investigates the effect of plasmonic nanoparticle geometry on the optical and photovoltaic performance of perovskite/CIGS tandem solar cells using three-dimensional finite-difference time-domain (FDTD) simulations and drift–diffusion device modeling. Three nanoparticle geometries—four-sided pyramidal, cubic, and cylindrical—were incorporated within the CIGS absorber to enhance light trapping through localized surface plasmon resonances (LSPRs) and plasmon-assisted scattering. All nanoparticle configurations improved absorption relative to the reference device, with the four-sided nanopyramid providing the most pronounced and broadband enhancement owing to its sharp-edge field localization and efficient scattering pathways; the numerical convergence of the optical results was confirmed through a quantitative mesh-independence analysis. Current–voltage analysis showed that the four-sided nanopyramid produced the highest short-circuit current density, followed by the cubic and cylindrical structures. Optimization of the pyramid dimensions revealed that for a = 75 nm (length, width, and height), the photocurrent approached 18 mA/cm 2 , compared with approximately 12 mA/cm 2 for the reference cell without nanoparticles. Based on the idealized photovoltaic model, this enhancement corresponds to a power-conversion efficiency (PCE) rise from 16.22 % (reference) to 26.27 % (optimized nanopyramid device). To evaluate the physical relevance of this result, drift–diffusion device simulations were additionally performed under ideal and realistic contact conditions. Under ideal-contact conditions, the nanopyramid-integrated device achieved a PCE of 24.80 %, in close agreement with the idealized model, whereas realistic-contact conditions, including series resistance and contact-related losses, reduced the PCE to 20.63 %. Carrier-generation rate distributions confirmed that sharp-tip geometries concentrate electromagnetic fields more effectively than smoother counterparts, producing stronger localized carrier generation.
No takes yet. Share an insight, caveat, or question.
Hamid Heidarzadeh (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: